ID-antibiotics

Side Effects of Antibiotics

  • General Overview

    • A high percentage of drug interactions occur, specifically between 1% to 4%.
    • Most interactions manifest as mild rashes.
    • Severe reactions are classified as extremely rare, occurring in less than one in one hundred thousand doses.

  • Penicillin Allergy

    • Cross-reactivity to penicillin for related allergies is noted at 3% to 5%; however, with newer antibiotics, this figure drops to about 1%.
    • Most allergic reactions are associated with specific side chains of the antibiotics, explaining cross-sensitivity (e.g., cephalexin and anticidin share similar side chains).

Antibiotic Classes and Their Applications

Cephalosporins

  • Third Generation: Ceftriaxone

    • Often referred to as a workhorse for treating gonorrhea (GC) and is utilized in various infections due to its broad effectiveness.
    • Commonly given in high doses ranging from 2 grams to 12 grams.

  • Fourth Generation: Cefepime

    • Primarily used for hospital-acquired infections and exhibits strong activity against Pseudomonas.

  • Fifth Generation: Ceftaroline

    • Approved for community-acquired pneumonia (CAP) and skin and soft tissue infections (SSTI).

  • Beta-Lactamase Inhibitors:

    • Clavulanate and sulbactam are particularly effective against plasmid-mediated beta-lactamases.

Side Effects

  • General Allergic Reactions
    • Occurrence of allergic reactions is between 3% to 10%, with oral formulations typically being a common culprit.
    • These reactions predominantly arise from components of side chains, rather than the parent drug itself.
    • Notable historical perspective reveals older individuals often recall adverse reactions attributed incorrectly to penicillin rather than its side chains.

Ampicillin/Sulbactam

  • Indications:
    • Used in cases of diabetes-related infections, intra-abdominal infections, and pelvic infections.
    • Administered for therapeutic antibiotic prophylaxis (TAP).
  • Formulation:
    • Given as a combination drug.
    • Administered at intervals of every 6 or 8 hours, with prolonged infusion times for optimal outcomes.

Carbapenems

  • General Utilization:
    • Employed for life-threatening infections due to their broader spectrum than penicillins.
  • Key Drugs:
    • Meropenem and Imipenem are combined with beta-lactamase inhibitors to combat resistant pathogens.
  • Side Effects:
    • Significant risk for seizures (about 1.5%), particularly in patients with preexisting conditions.
    • Meropenem associated with a slightly lower seizure risk relative to Imipenem.

Aminoglycosides

  • Mechanism of Action:
    • Inhibit bacterial protein synthesis and display concentration-dependent killing behaviors, with a noted post-antibiotic effect.
  • Dosing Considerations:
    • Advantageous when administered once daily to reduce nephrotoxicity compared to traditional dosing regimens.
  • Common Uses:
    • Generally used in combination therapies for infections such as endocarditis and pneumonia.
  • Side Effects:
    • Renal toxicity is common, though often reversible, and ototoxicity results in high-frequency deafness.

Macrolides

  • Key Drugs:
    • Includes erythromycin, clarithromycin, and azithromycin.
  • Indications and Coverage:
    • Erythromycin indicated for Chlamydia trachomatis.
    • Clarithromycin and azithromycin have enhanced gram-negative coverage and are effective against various protozoal infections.
  • Side Effects:
    • Notable side effects include gastrointestinal distress and the potential for prolonged QT intervals on ECG readings.

Tetracyclines

  • Key Drugs:
    • Doxycycline and minocycline.
  • Indications:
    • Doxycycline is indicated for syphilis treatment, particularly during penicillin shortages.
  • Side Effects:
    • Tetracyclines may cause vestibular side effects, particularly with minocycline and can occur more frequently in women.

Glycylcyclines

  • General Characteristics:
    • Related to tetracyclines and exhibit efficacy against most aerobic gram-positive bacteria.
  • Resistance Trends:
    • Increasing resistance observed, leading to reduced use for anaerobic infections but remaining valuable for MRSA.

Fluoroquinolones

  • Key Drugs:
    • Includes ciprofloxacin and levofloxacin.
  • Indications:
    • Primarily utilized for UTIs but pose risks of severe side effects, including QT prolongation and tendon ruptures.

Vancomycin

  • Usage in Prophylaxis:
    • Generally administered empirically during suspected bacterial infections, especially in hemodialysis patients.
  • Side Effects:
    • Thrombocytopenia and optic neuropathy (rare).

Daptomycin

  • Mechanism of Action:

    • Exerts action on gram-positive bacteria and has a concentration-dependent effect.

  • Key Side Effects:

    • Myopathy and eosinophilic pneumonia noted, especially after prolonged treatments.
    • Ineffective for pneumonia due to destruction by surfactant in the lungs.

  • Primary Applications:

    • Efficacious against MRSA, MSSA bacteremia, and VRE infections.